Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» EMA
EMA
EMA and FDA green-light MoonLake to advance IL-17 inhibitor
Clinical Trials Arena
Wed, 02/28/24 - 09:38 pm
MoonLake Immunotherapeutics
sonelokimab
FDA
EMA
hidradenitis suppurativa
US, EU regulators start swift reviews of Servier glioma drug
Pharmaphorum
Wed, 02/21/24 - 11:09 am
FDA
EMA
Servier
vorasidenib
glioma
brain cancer
PTC's re-examination bid for DMD drug Translarna falls short in Europe
Fierce Pharma
Fri, 01/26/24 - 11:10 am
PTC Therapeutics
EMA
Europe
Translarna
DMD
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Fri, 11/10/23 - 10:09 am
Bayer
EMA
Eylea
Roche
Santhera closes on first approval for DMD drug vamorolone
Pharmaphorum
Fri, 10/13/23 - 10:23 am
Santhera
Duchenne Muscular Dystrophy
DMD
vamorolone
EMA
Europe expects to decide on Novavax's COVID vaccine in October
Reuters
Thu, 09/21/23 - 10:33 am
Europe
EMA
Novavax
vaccines
COVID-19
EU clears review of Xtandi in earlier-stage prostate cancer
Pharmaphorum
Wed, 09/13/23 - 06:02 pm
EMA
Europe
Astellas
Pfizer
prostate cancer
Xtandi
Novartis sickle cell drug’s approval formally revoked by EU regulators
BioPharma Dive
Sun, 08/6/23 - 09:27 pm
Novartis
Adakveo
sickle cell disease
Europe
EMA
Controlling the pharma machine: EMA conveys thoughts on AI use in industry
Clinical Trials Arena
Sun, 07/23/23 - 12:22 pm
EMA
Europe
artificial intelligence
Europe recommends the approval of Pfizer’s RSV vaccine for older adults and in pregnancy
Stat
Fri, 07/21/23 - 10:13 am
Pfizer
vaccines
RSV
pregnancy
elderly
Europe
EMA
Astellas' Zolbetuximab Is a Promising Therapy for HER2-Negative Gastric Cancer
Xtalks
Mon, 07/17/23 - 06:54 pm
Astellas
zolbetuximab
gastric cancer
FDA
EMA
European regulators probe suicide risk to Ozempic, other Novo drug Saxenda
BioPharma Dive
Mon, 07/10/23 - 09:40 pm
Novo Nordisk
Ozempic
Saxenda
EMA
Europe
suicide
Ipsen and Genfit to file for EMA and FDA approval for elafibranor
Clinical Trials Arena
Fri, 06/30/23 - 10:12 am
Ipsen
Genfit
EMA
FDA
elafibranor
liver disease
primary biliary cholangitis
GSK’s daprodustat obtains positive opinion from EMA CHMP
Pharmaceutical Business Review
Tue, 06/27/23 - 10:12 am
EMA
Europe
GSK
CHMP
daprodustat
chronic kidney disease
EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's ALS Treatment
Benzinga
Fri, 06/23/23 - 09:51 am
Amylyx Pharmaceuticals
ALS
Albrioza
EMA
Europe
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
Yahoo/Reuters
Thu, 06/22/23 - 10:21 am
Novo Nordisk
EMA
semaglutide
Ozempic
Wegovy
thyroid cancer
obesity
diabetes
Amylyx’s ALS drug could face rejection in Europe
BioPharma Dive
Wed, 05/31/23 - 10:45 am
Amylyx
ALS
EMA
Europe
Relyvrio
EMA Panel Endorses Novavax's (NVAX) COVID vaccine for Full Approval
Yahoo/Zacks.com
Tue, 05/30/23 - 09:52 am
Novavax
EMA
Europe
vaccines
CHMP
COVID-19
Pharma fees to European regulator spike thanks to 10% inflation rate
Endpoints
Tue, 04/4/23 - 11:23 am
EMA
Europe
inflation
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
EMA
Europe
CHMP
Wegovy
Novo Nordisk
Bimervax
TG Therapeutics
Eli Lilly
Bristol Myers Squibb
Novartis
AstraZeneca
Pages
1
2
3
4
5
6
7
8
9
next ›
last »